大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/07 | 1,699 | 1,704 | 1,666 | 1,681 | +2 | +0.1% | 704,500 |
2021/01/06 | 1,650 | 1,698 | 1,640 | 1,679 | +28 | +1.7% | 865,500 |
2021/01/05 | 1,659 | 1,666 | 1,613 | 1,651 | -2 | -0.1% | 780,600 |
2021/01/04 | 1,615 | 1,659 | 1,597 | 1,653 | +41 | +2.5% | 798,600 |
2020/12/30 | 1,615 | 1,623 | 1,596 | 1,612 | -16 | -1% | 513,200 |
2020/12/29 | 1,593 | 1,634 | 1,582 | 1,628 | +14 | +0.9% | 608,800 |
2020/12/28 | 1,630 | 1,635 | 1,593 | 1,614 | -16 | -1% | 949,900 |
2020/12/25 | 1,632 | 1,644 | 1,616 | 1,630 | -4 | -0.2% | 566,200 |
2020/12/24 | 1,630 | 1,635 | 1,605 | 1,634 | +5 | +0.3% | 514,000 |
2020/12/23 | 1,619 | 1,635 | 1,601 | 1,629 | +19 | +1.2% | 481,000 |
2020/12/22 | 1,649 | 1,657 | 1,604 | 1,610 | -38 | -2.3% | 820,000 |
2020/12/21 | 1,659 | 1,671 | 1,625 | 1,648 | +36 | +2.2% | 1,083,700 |
2020/12/18 | 1,618 | 1,640 | 1,599 | 1,612 | ±0 | ±0% | 547,000 |
2020/12/17 | 1,607 | 1,627 | 1,596 | 1,612 | +9 | +0.6% | 634,700 |
2020/12/16 | 1,631 | 1,632 | 1,593 | 1,603 | -19 | -1.2% | 688,600 |
2020/12/15 | 1,641 | 1,658 | 1,606 | 1,622 | -16 | -1% | 786,000 |
2020/12/14 | 1,636 | 1,648 | 1,624 | 1,638 | +1 | +0.1% | 634,800 |
2020/12/11 | 1,615 | 1,637 | 1,593 | 1,637 | +17 | +1% | 737,900 |
2020/12/10 | 1,612 | 1,644 | 1,604 | 1,620 | +18 | +1.1% | 593,000 |
2020/12/09 | 1,611 | 1,617 | 1,595 | 1,602 | -9 | -0.6% | 487,300 |
2020/12/08 | 1,600 | 1,619 | 1,575 | 1,611 | -2 | -0.1% | 595,600 |
2020/12/07 | 1,643 | 1,651 | 1,606 | 1,613 | -20 | -1.2% | 575,000 |
2020/12/04 | 1,630 | 1,640 | 1,595 | 1,633 | -8 | -0.5% | 875,700 |
2020/12/03 | 1,660 | 1,660 | 1,630 | 1,641 | -25 | -1.5% | 746,400 |
2020/12/02 | 1,710 | 1,722 | 1,650 | 1,666 | -44 | -2.6% | 1,023,400 |
2020/12/01 | 1,698 | 1,732 | 1,691 | 1,710 | +25 | +1.5% | 700,100 |
2020/11/30 | 1,710 | 1,723 | 1,675 | 1,685 | -3 | -0.2% | 756,700 |
2020/11/27 | 1,683 | 1,710 | 1,666 | 1,688 | +4 | +0.2% | 696,800 |
2020/11/26 | 1,665 | 1,695 | 1,652 | 1,684 | +7 | +0.4% | 649,300 |
2020/11/25 | 1,708 | 1,724 | 1,662 | 1,677 | -48 | -2.8% | 1,090,900 |
2020/11/24 | 1,699 | 1,744 | 1,672 | 1,725 | -6 | -0.3% | 1,411,800 |
2020/11/20 | 1,799 | 1,810 | 1,705 | 1,731 | -17 | -1% | 1,471,700 |
2020/11/19 | 1,683 | 1,780 | 1,680 | 1,748 | +113 | +6.9% | 2,596,200 |
2020/11/18 | 1,615 | 1,684 | 1,608 | 1,635 | -11 | -0.7% | 1,524,200 |
2020/11/17 | 1,710 | 1,710 | 1,605 | 1,646 | -116 | -6.6% | 2,066,300 |
2020/11/16 | 1,796 | 1,826 | 1,745 | 1,762 | -21 | -1.2% | 1,150,600 |
2020/11/13 | 1,864 | 1,873 | 1,706 | 1,783 | -130 | -6.8% | 3,059,000 |
2020/11/12 | 1,937 | 1,958 | 1,866 | 1,913 | +14 | +0.7% | 1,433,100 |
2020/11/11 | 1,849 | 1,921 | 1,838 | 1,899 | +73 | +4% | 1,250,900 |
2020/11/10 | 2,004 | 2,008 | 1,801 | 1,826 | -180 | -9% | 1,977,500 |
2020/11/09 | 1,994 | 2,029 | 1,962 | 2,006 | +31 | +1.6% | 972,000 |
2020/11/06 | 2,003 | 2,006 | 1,955 | 1,975 | -16 | -0.8% | 859,600 |
2020/11/05 | 1,998 | 2,012 | 1,946 | 1,991 | +29 | +1.5% | 1,345,100 |
2020/11/04 | 1,920 | 1,966 | 1,906 | 1,962 | +64 | +3.4% | 928,600 |
2020/11/02 | 1,878 | 1,915 | 1,877 | 1,898 | +28 | +1.5% | 558,400 |
2020/10/30 | 1,906 | 1,930 | 1,858 | 1,870 | -30 | -1.6% | 990,000 |
2020/10/29 | 1,849 | 1,917 | 1,837 | 1,900 | +26 | +1.4% | 730,900 |
2020/10/28 | 1,879 | 1,923 | 1,837 | 1,874 | -14 | -0.7% | 777,800 |
2020/10/27 | 1,829 | 1,888 | 1,801 | 1,888 | +29 | +1.6% | 559,100 |
2020/10/26 | 1,891 | 1,896 | 1,849 | 1,859 | -19 | -1% | 540,100 |
951~
1000
件表示中 / 3839件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
市場注目の銘柄
チャート関連のコラム